ASTRAZENECA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.54 USD | +0.46% |
|
+2.13% | +16.61% |
| 24/05 | Innate Pharma: five abstracts selected for ASCO | CF |
| 24/05 | Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 73TCr | ||||||
| 60TCr | ||||||
| 35TCr | ||||||
| 33TCr | ||||||
| 28TCr |
